Legislation

Title: Income Tax - Biotechnology Investment Incentive Tax Credit - Alteration
Sponsored by: Senator King
Status: In the Senate - Hearing 3/13 at 1:00 p.m.
Analysis: Fiscal and Policy Note

Synopsis

Altering the definition of "qualified Maryland biotechnology company" to repeal certain limitations on the period of time for which a company may have been in active business for purposes of eligibility for the biotechnology tax credit; declaring the intent of the General Assembly that the credit will encourage private sector investment in Maryland biotechnology companies; altering a certain limitation on the aggregate credits that the Secretary of Commerce may certify for certain investments; applying the Act; etc.

Committees

Original:: Budget and Taxation Click to view Recorded Media

Details

Bill File Type: Regular

Effective Date(s): July 1, 2018

History

Legislation History
Chamber Senate Calendar Date 2/19/2018 Legislative Date 2/19/2018 Action First Reading Senate Rules Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Income Tax - Biotechnology Investment Incentive Tax Credit - Alteration Proceedings
Chamber Senate Calendar Date 2/23/2018 Legislative Date 2/23/2018 Action Rereferred to Budget and Taxation Proceedings
Chamber Senate Calendar Date 2/28/2018 Legislative Date 2/28/2018 Action Hearing 3/13 at 1:00 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
Senate	2/19/2018	2/19/2018	First Reading Senate Rules
			Text - First - Income Tax - Biotechnology Investment Incentive Tax Credit - Alteration
Senate	2/23/2018	2/23/2018	Rereferred to Budget and Taxation
Senate	2/28/2018	2/28/2018	Hearing 3/13 at 1:00 p.m.

File Code

Subjects

Statutes